European Medicines Agency (EMA) virtual press briefing -HPV Safety Review 2015

Jun 23, 2017 | Video

European Medicines Agency (EMA) virtual press briefing – Human papillomavirus (HPV) vaccines

Recommendation from the Pharmacovigilance Risk Assessment Committee (PRAC), 5th November 2015

Comparing reported Adverse Reactions to vaccines in UK

Independent-graph

Follow Us

Recent Tweets

A timely reminder of Dr Mehlsen's talk in 2019 at the Invest in ME conference where he described symptoms experienc�twitter.com/i/web/status/1…IA
1 week ago • Reply • Retweet • Favorite
RT @deddingtonian: @Taka_tut @PryorWhite Many girls have experienced disrupted menstrual cycles and excessively painful periods after the H…
1 week ago • Reply • Retweet • Favorite
RT @deddingtonian: Long-COVID-19 Patients Are Getting Diagnosed With Little-Known Illnesses Like POTS time.com/6051767/long-c…
4 months ago • Reply • Retweet • Favorite
RT @chrishendel: I'm still thinking about this very salient point raised by authors @MaryanneDemasi & Tom Jefferson in this important comme…
7 months ago • Reply • Retweet • Favorite
See comments, 2nd page, on the control arm of the clinical trials of the HPV vaccine. twitter.com/MaryanneDemasi…
7 months ago • Reply • Retweet • Favorite

Follow @TimeForActionUK

Pin It on Pinterest

Share This